While the initial research focused on the glibenclamide effect in ischemic stroke, mounting evidence underscores the central role of SUR1-TRPM4 also in secondary TBI injuries, particularly in contusional edema and hemorrhage progression (Jha et al., 2020, 2021). Here, TRPM4 is linked to ischemic stroke.